ConductScience.org, home

Paper39775320

The prognosis and immune repertoire characteristics of HBsAg and anti-HBs double positive chronic hepatitis B patients.

Liang H and 11 others. Clin Exp Med, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. The prognosis and immune repertoire characteristics of HBsAg and anti-HBs double positive chronic hepatitis B patients. Papers, record 39775320. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39775320

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The prognosis and immune repertoire characteristics of HBsAg and anti-HBs double positive chronic hepatitis B patients.
PubMed
Journal
Clin Exp Med
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-12-05
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liang HHuijun
2Wang HHaifang
3Liang MMinfeng
4Zhang XXiaobin
5Dai MMeifen
6Li HHaixia
7Li XXin
8Yin XXiaofeng
9Liu XXinyao
10Yao JJiaqi
11Guan ZZiyun
12Qiu YYurong

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis B, ChronicMajor topic
Hepatitis B Surface AntigensMajor topic
Hepatitis B AntibodiesMajor topic
Humans
Male
Female
Middle Aged
Adult
Prognosis
Retrospective Studies
China
Immunoglobulin Heavy Chains
Young Adult
Aged
Receptors, Antigen, B-Cell

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No. 2320001006088Foshan science and technology plan projectPubMed
No. 202102020024Guangzhou science and technology plan projectPubMed
No. 2022J007Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical UniversityPubMed
No. 81871712National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137024566Global burden of hepatitis B virus: current status, missed opportunities and a call for action.Nat Rev Gastroenterol Hepatol2023https://conductscience.org/library/papers/37024566PubMed
237719965Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022).J Clin Transl Hepatol2023https://conductscience.org/library/papers/37719965PubMed
316447285Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005.Hepatology2006https://conductscience.org/library/papers/16447285PubMed
417628874Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase.Hepatology2007https://conductscience.org/library/papers/17628874PubMed
533867835Paradoxical HBsAg and anti-HBs coexistence among Chronic HBV Infections: Causes and Consequences.Int J Biol Sci2021https://conductscience.org/library/papers/33867835PubMed
626010146Sequence analysis of the HBV S protein in Chinese patients with coexisting HBsAg and anti-HBs antibodies.J Med Virol2015https://conductscience.org/library/papers/26010146PubMed
721840251Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.J Clin Virol2011https://conductscience.org/library/papers/21840251PubMed
824127328Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.J Med Virol2014https://conductscience.org/library/papers/24127328PubMed
911696228
Characterization of a novel hepatitis B virus mutant: demonstration of mutation-induced hepatitis B virus surface antigen group specific "a" determinant conformation change and its application in diagnostic assays.
Transfus Med2001https://conductscience.org/library/papers/11696228PubMed
1019623669Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.J Med Virol2009https://conductscience.org/library/papers/19623669PubMed
1116501106Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants.J Virol2006https://conductscience.org/library/papers/16501106PubMed
1210535488Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen.J Gastroenterol1999https://conductscience.org/library/papers/10535488PubMed
1325542467Coexistence of circulating HBsAg and anti-HBs antibodies in chronic hepatitis B carriers is not a simple analytical artifact and does not influence HBsAg quantification.J Clin Virol2015https://conductscience.org/library/papers/25542467PubMed
1428198078Mutation in the S gene of hepatitis B virus and anti-HBs subtype-nonspecificity contributed to the co-existence of HBsAg and anti-HBs in patients with chronic hepatitis B virus infection.J Med Virol2017https://conductscience.org/library/papers/28198078PubMed
1526963138Current status and recent advances of next generation sequencing techniques in immunological repertoire.Genes Immun2016https://conductscience.org/library/papers/26963138PubMed
1634522220The methods and advances of adaptive immune receptors repertoire sequencing.Theranostics2021https://conductscience.org/library/papers/34522220PubMed
1734722192Guidelines for Prevention and Treatment of Chronic Hepatitis B.J Clin Transl Hepatol2021https://conductscience.org/library/papers/34722192PubMed
1817573090Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers.Virology2007https://conductscience.org/library/papers/17573090PubMed
1925953851The MEME Suite.Nucleic Acids Res2015https://conductscience.org/library/papers/25953851PubMed
2026663578Epidemiological characteristics of the carriers with coexistence of HBsAg and anti-HBs based on a community cohort study.J Viral Hepat2016https://conductscience.org/library/papers/26663578PubMed

See all 36 referencesDownload CSV of references

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39775320

GET https://conductscience.org/api/papers/v1/39775320/references?page=2